• 1. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 2. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

Recent Advances in the Study of 5-((Benzyloxy)methoxy)-4-oxo-4H-pyran-2-carboxylic acid (CAS: 1381946-81-1)

The compound 5-((Benzyloxy)methoxy)-4-oxo-4H-pyran-2-carboxylic acid (CAS: 1381946-81-1) has recently garnered significant attention in the field of chemical biology and medicinal chemistry due to its unique structural properties and potential therapeutic applications. This research briefing aims to provide an overview of the latest advancements related to this compound, focusing on its synthesis, biological activity, and potential applications in drug development.

Recent studies have highlighted the role of 5-((Benzyloxy)methoxy)-4-oxo-4H-pyran-2-carboxylic acid as a key intermediate in the synthesis of biologically active molecules. Its pyran-2-carboxylic acid core structure is particularly noteworthy for its ability to interact with various biological targets, including enzymes and receptors involved in inflammatory and metabolic pathways. Researchers have employed advanced synthetic techniques, such as multi-step organic synthesis and catalytic reactions, to optimize the yield and purity of this compound.

In a groundbreaking study published in the Journal of Medicinal Chemistry, scientists demonstrated the compound's efficacy as a modulator of specific kinase enzymes, which are implicated in cancer progression. The study utilized in vitro assays and molecular docking simulations to elucidate the binding interactions between 5-((Benzyloxy)methoxy)-4-oxo-4H-pyran-2-carboxylic acid and its target proteins. The results indicated a high affinity and selectivity, suggesting its potential as a lead compound for the development of novel kinase inhibitors.

Another area of interest is the compound's application in antimicrobial research. A recent publication in Bioorganic & Medicinal Chemistry Letters reported that derivatives of 5-((Benzyloxy)methoxy)-4-oxo-4H-pyran-2-carboxylic acid exhibited potent activity against a range of Gram-positive and Gram-negative bacteria. The study emphasized the importance of the benzyloxy moiety in enhancing the compound's bioavailability and stability, which are critical factors for its therapeutic use.

Despite these promising findings, challenges remain in the clinical translation of 5-((Benzyloxy)methoxy)-4-oxo-4H-pyran-2-carboxylic acid. Issues such as pharmacokinetic properties, toxicity profiles, and scalability of synthesis need to be addressed in future research. Collaborative efforts between academic institutions and pharmaceutical companies are essential to overcome these hurdles and unlock the full potential of this compound.

In conclusion, 5-((Benzyloxy)methoxy)-4-oxo-4H-pyran-2-carboxylic acid represents a versatile and promising scaffold in medicinal chemistry. Its diverse biological activities and synthetic accessibility make it a valuable candidate for further exploration. Continued research efforts are expected to yield new insights into its mechanisms of action and therapeutic applications, paving the way for innovative drug discoveries.

• 892152-75-9(5-(Benzyloxy)-2-(benzyloxymethyl)-4H-pyran-4-one)
• 216581-77-0(4H-Pyran-4-one, 2-(hydroxymethyl)-6-methyl-3-(phenylmethoxy)-)
• 1040717-19-8(5-(4-Chlorobenzyloxy)-4-oxo-4H-pyran-2-carboxylic acid)
• 108352-97-2(5-(4-methoxybenzyloxy)-4-oxo-4H-pyran-2-carboxylic acid)
• 123377-45-7(4H-Pyran-4-one, 5-hydroxy-2-(hydroxymethyl)-, monobenzoate)
• 15771-06-9(5-(Benzyloxy)-2-(hydroxymethyl)-4H-pyran-4-one)
• 1219-33-6(5-(Benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid)
• 216581-47-4(4H-Pyran-2-carboxylic acid, 6-methyl-4-oxo-3-(phenylmethoxy)-)
• 154150-75-1(2-Propenoic acid, 3-[4-oxo-5-(phenylmethoxy)-4H-pyran-2-yl]-)
• 119736-16-2(3-(Benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid)